| Filed On | Filing |
|---|---|
| 30 Apr 2026 |
8-K/A: Departure/Election of Directors or Officers; Compensation
On April 29, 2026 (the “Effective Date”), the Separation Agreement between the Company and Dr. Sullivan became binding and effective, addressing Dr. Sullivan’s separation from the Company. Also on the Effective Date, Dr. Sullivan resigne... |
| 27 Oct 2023 |
8-K/A: Financial Statements and Exhibits
We have audited the accompanying consolidated balance sheets of Apexigen, Inc. (the “Company”) as of December 31, 2022 and 2021, the related consolidated statements of operations and comprehensive loss, stockholders’ equity, and cash flo... |
Loading...
